{"transactions":[{"id":712555,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-08T21:16:50.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1106,"price":2.71,"value":2997.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":1060087,"source":{"system":"sec-edgar","filing":"0001417952-26-000002","document":"wk-form4_1783545408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141795226000002/wk-form4_1783545408.xml","form_type":"4"}},{"id":800005,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-04-27T12:33:59.000Z","date":"2026-04-24","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.61,"exercise_date":"2017-11-16","expiration_date":"2026-11-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001417952-26-000001","document":"wk-form4_1777293236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141795226000001/wk-form4_1777293236.xml","form_type":"4"}},{"id":800004,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-27T12:33:59.000Z","date":"2026-04-24","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":2.61,"value":52200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person exercised the stock options reported on this Form 4 in advance of their expiration on November 15, 2026, paying the exercise price with cash, and has not sold any of the shares received upon exercise."}],"balance_after":1058981,"source":{"system":"sec-edgar","filing":"0001417952-26-000001","document":"wk-form4_1777293236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141795226000001/wk-form4_1777293236.xml","form_type":"4"}},{"id":884524,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2026-02-24T21:44:59.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":503937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option shall vest on each anniversary of the grant date."}],"balance_after":503937,"derivative":{"exercise_price":4.94,"exercise_date":"2027-02-19","expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":503937},"source":{"system":"sec-edgar","filing":"0001628280-26-011159","document":"wk-form4_1771969496.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828026011159/wk-form4_1771969496.xml","form_type":"4"}},{"id":1174634,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-04-09T23:52:42.000Z","date":"2025-04-09","kind":"exercise","planned":false,"acquired":false,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.3,"exercise_date":"2015-08-30","expiration_date":"2025-07-29","underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001628280-25-017223","document":"wk-form4_1744242755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828025017223/wk-form4_1744242755.xml","form_type":"4"}},{"id":1174633,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-09T23:52:42.000Z","date":"2025-04-09","kind":"exercise","planned":false,"acquired":true,"shares":66667,"price":3.3,"value":220001.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised the stock options reported on this Form 4 in advance of their expiration on July 29, 2025, paying the exercise price with cash, and has not sold any of the shares received upon exercise."}],"balance_after":1038981,"source":{"system":"sec-edgar","filing":"0001628280-25-017223","document":"wk-form4_1744242755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828025017223/wk-form4_1744242755.xml","form_type":"4"}},{"id":1240506,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Unit","published_at":"2025-02-27T21:42:35.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":1518600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the company's common stock when vested. The PSUs vest incrementally upon the Company's common stock achieving specified price per share performance goals and continued employment prior to February 25, 2032, and subject to a change in control."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the company's common stock when vested. The PSUs vest incrementally upon the Company's common stock achieving specified price per share performance goals and continued employment prior to February 25, 2032, and subject to a change in control."}],"balance_after":1518600,"derivative":{"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":1518600},"source":{"system":"sec-edgar","filing":"0001628280-25-008721","document":"wk-form4_1740692548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828025008721/wk-form4_1740692548.xml","form_type":"4"}},{"id":1267043,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2025-02-14T23:17:07.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":492278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on February 12, 2026 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":492278,"derivative":{"exercise_price":5.48,"exercise_date":"2026-02-12","expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":492278},"source":{"system":"sec-edgar","filing":"0001628280-25-005851","document":"wk-form4_1739575019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828025005851/wk-form4_1739575019.xml","form_type":"4"}},{"id":1622347,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2024-02-24T01:59:47.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":399568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on February 22, 2025 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":399568,"derivative":{"exercise_price":1.52,"exercise_date":"2025-02-22","expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":399568},"source":{"system":"sec-edgar","filing":"0001628280-24-006724","document":"wk-form4_1708739974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828024006724/wk-form4_1708739974.xml","form_type":"4"}},{"id":1871805,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T20:27:50.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":1.42,"value":9940.0,"ownership":{"direct":false,"nature":"By Fried-Travis Revocable Trust U/A Dated 06/02/1999"},"balance_after":95001,"source":{"system":"sec-edgar","filing":"0001628280-23-020508","document":"wk-form4_1685651259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828023020508/wk-form4_1685651259.xml","form_type":"4"}},{"id":2007308,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Cheif Executive Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2023-02-17T22:05:37.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":306366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on February 15, 2024 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":306366,"derivative":{"exercise_price":1.82,"exercise_date":"2024-02-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":306366},"source":{"system":"sec-edgar","filing":"0001628280-23-004086","document":"wf-form4_167667149838499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828023004086/wf-form4_167667149838499.xml","form_type":"4"}},{"id":2147163,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Cheif Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-04T00:17:32.000Z","date":"2022-09-30","kind":"purchase","acquired":true,"shares":80000,"price":1.25,"value":100000.0,"ownership":{"direct":true},"balance_after":972314,"source":{"system":"sec-edgar","filing":"0001628280-22-025915","document":"wf-form4_166484261652383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828022025915/wf-form4_166484261652383.xml","form_type":"4"}},{"id":2330577,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-16T23:28:43.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":25000,"price":2.16,"value":54000.0,"ownership":{"direct":false,"nature":"By Fried-Travis Revocable Trust U/A Dated 06/02/1999"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.16, and the range of prices were between $2.14 and $2.16, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided."}],"balance_after":88001,"source":{"system":"sec-edgar","filing":"0001628280-22-006443","document":"wf-form4_164747330857843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828022006443/wf-form4_164747330857843.xml","form_type":"4"}},{"id":2382047,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2022-02-22T22:28:55.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":240448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on February 17, 2023 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":240448,"derivative":{"exercise_price":2.67,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":240448},"source":{"system":"sec-edgar","filing":"0001628280-22-003371","document":"wf-form4_164556891215777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000162828022003371/wf-form4_164556891215777.xml","form_type":"4"}},{"id":2710200,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-05-17T12:30:11.000Z","date":"2021-05-13","kind":"purchase","acquired":true,"shares":10000,"price":6.65,"value":66500.0,"ownership":{"direct":false,"nature":"By Fried-Travis Revocable Trust U/A Dated 06/02/1999"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $6.65, and the range of prices were between $6.64 and $6.66.  Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":63001,"source":{"system":"sec-edgar","filing":"0001415889-21-002499","document":"form4-05172021_080502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588921002499/form4-05172021_080502.xml","form_type":"4"}},{"id":2763796,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-01T23:24:46.000Z","date":"2020-04-17","kind":"gift","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 17, 2020, the Reporting Person transferred an aggregate of 500,000 shares to trusts established for the benefit of his children as follows:  250,000 shares to US Trust Company of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020 and 250,000 shares to US Trust Company of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"1,000 shares held by the Reporting Person were inadvertently reported on a prior Form 4 filing as held directly.  Instead, the shares are held by the Reporting Person indirectly in the name of the Fried-Travis Revocable Trust U/A Dated 06/02/1999."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"9,753 shares held by the Reporting Person were inadvertently reported on prior Form 4 filings as held directly.  Instead, the shares are held by the Reporting Person indirectly in the name of Fried Films Profit Sharing."}],"balance_after":882561,"source":{"system":"sec-edgar","filing":"0001415889-21-001778","document":"form4-04012021_040432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588921001778/form4-04012021_040432.xml","form_type":"4"}},{"id":2781860,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2021-03-17T22:43:25.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":55921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 33% on March 15, 2022 and thereafter 1/36th vest each month."}],"balance_after":55921,"derivative":{"exercise_price":11.83,"exercise_date":"2022-03-15","expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":55921},"source":{"system":"sec-edgar","filing":"0001415889-21-001547","document":"form4-03172021_030338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588921001547/form4-03172021_030338.xml","form_type":"4"}},{"id":3142487,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-19T20:34:57.000Z","date":"2020-05-19","kind":"purchase","acquired":true,"shares":1000,"price":4.69,"value":4690.0,"ownership":{"direct":true},"balance_after":1393314,"source":{"system":"sec-edgar","filing":"0001415889-20-001263","document":"form4-05192020_010544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588920001263/form4-05192020_010544.xml","form_type":"4"}},{"id":3243719,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2020-02-28T01:23:32.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":165155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 33% on February 25, 2021 and thereafter 1/36th vest each month."}],"balance_after":165155,"derivative":{"exercise_price":3.27,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":165155},"source":{"system":"sec-edgar","filing":"0001415889-20-000544","document":"form4-02272020_050218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588920000544/form4-02272020_050218.xml","form_type":"4"}},{"id":3270435,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-14T21:10:46.000Z","date":"2019-02-15","kind":"gift","acquired":true,"shares":52001,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fried-Travis Revocable Trust U/A Dated 06/02/1999"},"balance_after":52001,"source":{"system":"sec-edgar","filing":"0001415889-20-000337","document":"form5-02142020_010232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588920000337/form5-02142020_010232.xml","form_type":"5"}},{"id":3270434,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-14T21:10:46.000Z","date":"2019-02-15","kind":"gift","acquired":false,"shares":52001,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1392314,"source":{"system":"sec-edgar","filing":"0001415889-20-000337","document":"form5-02142020_010232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588920000337/form5-02142020_010232.xml","form_type":"5"}},{"id":3369804,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-11-15T15:49:39.000Z","date":"2019-11-14","kind":"purchase","acquired":true,"shares":10000,"price":3.09,"value":30900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Previous Form 4's disclosing the Reporting Person's beneficial ownership inadvertently overstated the number of shares directly beneficially owned by the Reporting Person by 2,012 shares.  The number of shares is corrected in this Form 4."}],"balance_after":1444315,"source":{"system":"sec-edgar","filing":"0001415889-19-001311","document":"form4-11152019_071126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588919001311/form4-11152019_071126.xml","form_type":"4"}},{"id":3429181,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-08-26T12:00:16.000Z","date":"2019-08-23","kind":"purchase","acquired":true,"shares":2500,"price":4.03,"value":10075.0,"ownership":{"direct":true},"balance_after":1436327,"source":{"system":"sec-edgar","filing":"0001415889-19-000953","document":"form4-08262019_080802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588919000953/form4-08262019_080802.xml","form_type":"4"}},{"id":3515070,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-05-22T20:38:05.000Z","date":"2019-05-21","kind":"purchase","acquired":true,"shares":2253,"price":4.43,"value":9980.79,"ownership":{"direct":true},"balance_after":1433827,"source":{"system":"sec-edgar","filing":"0001415889-19-000563","document":"form4-05222019_010552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588919000563/form4-05222019_010552.xml","form_type":"4"}},{"id":3592570,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-03-16T00:14:03.000Z","date":"2019-03-15","kind":"purchase","acquired":true,"shares":5000,"price":3.8,"value":19000.0,"ownership":{"direct":true},"balance_after":1431574,"source":{"system":"sec-edgar","filing":"0001415889-19-000338","document":"form4-03152019_050350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588919000338/form4-03152019_050350.xml","form_type":"4"}},{"id":3592569,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-03-16T00:14:03.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":166666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These fully-vested shares are awarded to Mr. Fried pursuant to the achievement of the performance criteria detailed in his Executive Employment Agreement, dated March 12, 2017, as amended."}],"balance_after":1426574,"source":{"system":"sec-edgar","filing":"0001415889-19-000338","document":"form4-03152019_050350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588919000338/form4-03152019_050350.xml","form_type":"4"}},{"id":3638597,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2019-02-23T00:37:06.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":162569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 33% on February 21, 2020 and thereafter 1/36th vest each month."}],"balance_after":162569,"derivative":{"exercise_price":3.84,"exercise_date":"2020-02-21","expiration_date":"2029-02-21","underlying":"Common Stock","underlying_shares":162569},"source":{"system":"sec-edgar","filing":"0001415889-19-000221","document":"form4-02222019_040253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588919000221/form4-02222019_040253.xml","form_type":"4"}},{"id":3769440,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-09T22:18:12.000Z","date":"2018-11-07","kind":"grant","acquired":true,"shares":166667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These fully-vested shares are awarded to Mr. Fried pursuant to the achievement of the performance criteria detailed in his Executive Employment Agreement, dated March 12, 2017, as amended."}],"balance_after":1259908,"source":{"system":"sec-edgar","filing":"0001415889-18-001610","document":"form4-11092018_021156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588918001610/form4-11092018_021156.xml","form_type":"4"}},{"id":3882963,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-26T21:17:22.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":744097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Awarded pursuant to his Amended and Restated Executive Employment Agreement dated June 22, 2018, in consideration of his appointment by the Board to CEO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3rd of the shares vest on June 22, 2019 and the remaining shares vest in a series of 24 equal monthly installments thereafter."}],"balance_after":744097,"derivative":{"exercise_price":3.83,"exercise_date":"2019-06-22","expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":744097},"source":{"system":"sec-edgar","filing":"0001415889-18-001033","document":"form4-06262018_020606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588918001033/form4-06262018_020606.xml","form_type":"4"}},{"id":3882962,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-06-26T21:17:22.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":166667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These fully-vested shares are awarded to Mr. Fried pursuant to the achievement of the performance criteria detailed in his Executive Employment Agreement, dated March 12, 2017, as amended."}],"balance_after":1093241,"source":{"system":"sec-edgar","filing":"0001415889-18-001033","document":"form4-06262018_020606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588918001033/form4-06262018_020606.xml","form_type":"4"}},{"id":3930708,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, COO"}}],"security":"Common Stock","published_at":"2018-05-16T16:10:23.000Z","date":"2018-05-15","kind":"purchase","acquired":true,"shares":10000,"price":3.63,"value":36300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being amended to correct the transaction code to reflect that the shares were purchased by the Reporting Person on the open market."}],"balance_after":926574,"source":{"system":"sec-edgar","filing":"0001415889-18-000742","document":"form4a-05162018_090510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588918000742/form4a-05162018_090510.xml","form_type":"4/A","original_submission_date":"2018-05-15"}},{"id":3932741,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, COO"}}],"security":"Common Stock","published_at":"2018-05-15T21:34:49.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":10000,"price":3.63,"value":36300.0,"ownership":{"direct":true},"balance_after":926574,"source":{"system":"sec-edgar","filing":"0001415889-18-000738","document":"form4-05152018_020536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588918000738/form4-05152018_020536.xml","form_type":"4"}},{"id":4092317,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, COO, CSO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2018-01-23T21:19:54.000Z","date":"2018-01-21","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"10/36th of the shares vested on January 21, 2018 and thereafter 1/36th vest on the 12th of each month for the next 26 months."}],"balance_after":300000,"derivative":{"exercise_price":5.85,"exercise_date":"2018-01-21","expiration_date":"2028-01-21","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-18-000106","document":"form4-01232018_010141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588918000106/form4-01232018_010141.xml","form_type":"4"}},{"id":4123535,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CHIEF STRATEGY OFF."}}],"security":"Common Stock","published_at":"2017-12-21T22:46:44.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":333333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 20, 2017, ChromaDex Corporation (the \"Company\") and Robert Fried entered into an amendment (the \"Amendment\") to Mr. Fried's existing Executive Employment Agreement, dated March 12, 2017.  In connection with the Amendment, the Company granted to Mr. Fried 333,333 shares of restricted Common Stock pursuant to the Company's 2017 Equity Incentive Plan, which shares are fully-vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 166,667 shares of restricted Common Stock previously granted by the Company on March 12, 2017.  In connection with the Amendment,  the Company accelerated in full the vesting of the 166,667 shares of restricted Common Stock previously granted to Mr. Fried on March 12, 2017."}],"balance_after":916574,"source":{"system":"sec-edgar","filing":"0001415889-17-001978","document":"form4-12212017_021233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588917001978/form4-12212017_021233.xml","form_type":"4"}},{"id":4232294,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CHIEF STRATEGY OFF."}}],"security":"Common Stock","published_at":"2017-08-16T20:50:08.000Z","date":"2017-08-15","kind":"purchase","acquired":true,"shares":10000,"price":3.15,"value":31500.0,"ownership":{"direct":true},"balance_after":583241,"source":{"system":"sec-edgar","filing":"0001415889-17-001399","document":"form4-08162017_010858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588917001399/form4-08162017_010858.xml","form_type":"4"}},{"id":4351560,"issuer":{"id":6736,"kind":"organization","name":"Fluent, Inc.","symbol":"FLNT"},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T20:46:00.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On April 13, 2017, the reporting person received a grant of 15,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on\na one-for-one basis. The RSUs vest in three approximately equal installments on June 1, 2017, 2018 and 2019, subject to accelerated vesting\nunder certain conditions."},{"field":"security","element":"securityTitle","label":"F2","text":"Within 30 days of the effective grant date, the reporting person may elect to defer delivery of any vested RSUs until a later date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 13, 2017, the reporting person received a grant of 15,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on\na one-for-one basis. The RSUs vest in three approximately equal installments on June 1, 2017, 2018 and 2019, subject to accelerated vesting\nunder certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 13, 2017, the reporting person received a grant of 15,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on\na one-for-one basis. The RSUs vest in three approximately equal installments on June 1, 2017, 2018 and 2019, subject to accelerated vesting\nunder certain conditions."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-17-027064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460329/000120919117027064/doc4.xml","form_type":"4"}},{"id":4386263,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CHIEF STRATEGY OFF."}}],"security":"Employee Stock Options (right to buy)","published_at":"2017-03-14T21:26:17.000Z","date":"2017-03-12","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The options were awarded pursuant to his employment with the issuer as President and Chief Strategy Officer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vest in equal monthly installments over three years."}],"balance_after":500000,"derivative":{"exercise_price":2.715,"exercise_date":"2017-04-12","expiration_date":"2027-03-12","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-17-000415","document":"form4-03142017_020307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588917000415/form4-03142017_020307.xml","form_type":"4"}},{"id":4386262,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CHIEF STRATEGY OFF."}}],"security":"Common Stock","published_at":"2017-03-14T21:26:17.000Z","date":"2017-03-12","kind":"grant","acquired":true,"shares":166667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These are shares of restricted stock and were awarded pursuant to his employment  with the issuer as President and Chief Strategy Officer.  1/3rd will vest on March 12, 2018, 1/3rd will vest on March 12, 2019 and 1/3rd will vest on March 12, 2020."}],"balance_after":573241,"source":{"system":"sec-edgar","filing":"0001415889-17-000415","document":"form4-03142017_020307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588917000415/form4-03142017_020307.xml","form_type":"4"}},{"id":4386261,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CHIEF STRATEGY OFF."}}],"security":"Common Stock","published_at":"2017-03-14T21:26:17.000Z","date":"2017-03-12","kind":"grant","acquired":true,"shares":339595,"price":2.72,"value":923698.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for the membership interests of Healthspan Research, LLC (\"Healthspan\") previously owned by the Reporting Person, valued at $923,697.41, in connection with the acquisition of the outstanding membership interests of Healthspan by ChromaDex Corporation (the \"Company\") (the \"Acquisition\").  The number of shares received by the Reporting Person was calculated using the closing bid price per share of the Company's common stock on the NASDAQ Capital Market on the last trading day before the effective date of the Acquisition, rounded up to the nearest share.  The closing bid price of the Company's common stock on March 10, 2017, rounded up to the nearest share, was $2.72 per share."}],"balance_after":406574,"source":{"system":"sec-edgar","filing":"0001415889-17-000415","document":"form4-03142017_020307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588917000415/form4-03142017_020307.xml","form_type":"4"}},{"id":4548645,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Options (right to buy)","published_at":"2016-11-18T21:42:47.000Z","date":"2016-11-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on November 16, 2017."}],"balance_after":20000,"derivative":{"exercise_price":2.605,"exercise_date":"2017-11-16","expiration_date":"2026-11-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-16-007480","document":"form4-11182016_011138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588916007480/form4-11182016_011138.xml","form_type":"4"}},{"id":4563846,"issuer":{"id":6736,"kind":"organization","name":"Fluent, Inc.","symbol":"FLNT"},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-08T12:53:02.000Z","date":"2016-11-07","kind":"purchase","acquired":true,"shares":2000,"price":3.75,"value":7500.0,"ownership":{"direct":true},"balance_after":337338,"source":{"system":"sec-edgar","filing":"0001209191-16-148772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460329/000120919116148772/doc4.xml","form_type":"4"}},{"id":4611025,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31423,"kind":"person","name":"Fried Robert N","position":1,"cik":"0001417952","reported_name":"Fried Robert N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-06T20:17:56.000Z","date":"2016-09-01","kind":"purchase","acquired":true,"shares":15000,"price":3.39,"value":50850.0,"ownership":{"direct":true},"balance_after":66979,"source":{"system":"sec-edgar","filing":"0001415889-16-007054","document":"form4-09062016_010946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417952/000141588916007054/form4-09062016_010946.xml","form_type":"4"}}]}